Literature DB >> 30717905

Evolving Understanding of the Epidemiology of Thyroid Cancer.

Carolyn Dacey Seib1, Julie Ann Sosa2.   

Abstract

The incidence of thyroid cancer worldwide has increased significantly over the past 3 decades, due predominantly to an increase in papillary thyroid cancer. Although most of these cancers are small and localized, population-based studies have documented a significant increase in thyroid cancers of all sizes and stages, in addition to incidence-based mortality for papillary thyroid cancer. This suggests that the increasing incidence of thyroid cancer is due in large part to increasing surveillance and overdiagnosis, but that there also appears to be a true increase in new cases of thyroid cancer.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Environmental exposure; Epidemiology; Incidence; Papillary thyroid cancer; Thyroid cancer

Mesh:

Year:  2018        PMID: 30717905     DOI: 10.1016/j.ecl.2018.10.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  82 in total

1.  Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression.

Authors:  Yu Sun; Tiefeng Shi; Yanfei Ma; Huadong Qin; Kang Li
Journal:  Cell Cycle       Date:  2020-02-20       Impact factor: 4.534

2.  Lysyl oxidase promotes anaplastic thyroid carcinoma cell proliferation and metastasis mediated via BMP1.

Authors:  Yujia Liu; Yiwen Zhang; Zhuo Tan; Jiafeng Wang; Ying Hu; Jiao Sun; Meihua Bao; Ping Huang; Minghua Ge; Young Jun Chai; Chuanming Zheng
Journal:  Gland Surg       Date:  2022-01

Review 3.  Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.

Authors:  Gabriel B K Sasa; Cheng Xuan; Guoliang Lyu; Xianfeng Ding; Fang Meiyu
Journal:  Mol Biotechnol       Date:  2022-01-31       Impact factor: 2.695

Review 4.  The Thyroid Tumor Microenvironment: Potential Targets for Therapeutic Intervention and Prognostication.

Authors:  Laura MacDonald; Jonathan Jenkins; Grace Purvis; Joshua Lee; Aime T Franco
Journal:  Horm Cancer       Date:  2020-06-17       Impact factor: 3.869

Review 5.  Notch Signaling in Thyroid Cancer.

Authors:  Rachael Guenter; Zeelu Patel; Herbert Chen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Evaluation of Medical Surveillance and Incidence of Post-September 11, 2001, Thyroid Cancer in World Trade Center-Exposed Firefighters and Emergency Medical Service Workers.

Authors:  Hilary L Colbeth; Natalia Genere; Charles B Hall; Nadia Jaber; Juan P Brito; Omar M El Kawkgi; David G Goldfarb; Mayris P Webber; Theresa M Schwartz; David J Prezant; Rachel Zeig-Owens
Journal:  JAMA Intern Med       Date:  2020-06-01       Impact factor: 21.873

7.  Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.

Authors:  Tianjun Wei; Xiangming Zhu
Journal:  J Bioenerg Biomembr       Date:  2021-05-25       Impact factor: 2.945

8.  ZFPM2-AS1 transcriptionally mediated by STAT1 regulates thyroid cancer cell growth, migration and invasion via miR-515-5p/TUSC3.

Authors:  Ruizhen Ren; Yuanna Du; Xing Niu; Rukun Zang
Journal:  J Cancer       Date:  2021-04-17       Impact factor: 4.207

9.  The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC).

Authors:  Chiara Mele; Marina Caputo; Maria Teresa Samà; Valentina Bullara; Maria Grazia Mauri; Flavia Prodam; Gianluca Aimaretti; Loredana Pagano; Paolo Marzullo
Journal:  Eur J Clin Nutr       Date:  2020-06-09       Impact factor: 4.016

Review 10.  The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy.

Authors:  Amandeep Singh; Jeehoon Ham; Joseph William Po; Navin Niles; Tara Roberts; Cheok Soon Lee
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.